✦ LIBER ✦

Insulin glargine is cost-effective in treatment of patients with diabetes type-2 in whom nph insulin does not provide adequate glycaemic control – The case of poland

✍ Scribed by Szmurlo, D.; Kostrzewska, K.; Fundament, T.; Kopec, G.; Wojtarowicz, M.; Drzal, R.; Stawujak, G.; Labak-Klimasara, M.; Glasek, M.; Lis, J.; Plisko, R.

Book ID: 123352418
Publisher: John Wiley and Sons
Year: 2013
Tongue: English
Weight: 72 KB
Volume: 16
Category: Article
ISSN: 1098-3015
DOI: 10.1016/j.jval.2013.03.824

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PDB18 THE RELATIVE COST EFFECTIVENESS OF

PDB18 THE RELATIVE COST EFFECTIVENESS OF INSULIN GLARGINE VERSUS NPH INSULIN USING UK REAL LIFE DATA IN PATIENTS WITH TYPE 2 DIABETES MELLITUS

✍ P McEwan; N Mehin; AP Tetlow; P Sharplin 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 86 KB

PDB39 IS INSULIN GLARGINE A COST EFFECTI

PDB39 IS INSULIN GLARGINE A COST EFFECTIVE OPTION IN TREATMENT OF PATIENTS WITH TYPE DM1 WITH BASELINE HBA1C ABOVE 8% IN COMPARISON TO NPH AND PREMIX IN POLAND?

✍ P McEwan; A Woehl; P Kawalec; J Lis; J Gierczynski; J Walczak 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB

PDB37 IS INSULIN GLARGINE A COST-EFFECTI

PDB37 IS INSULIN GLARGINE A COST-EFFECTIVE OPTION FOR TREATMENT OF PATIENTS NAÏVE TO INSULIN TREATMENT WITH TYPE 2, BASELINE HBA1C ABOVE 8% AND AGE BELOW 65YEARS IN COMPARISON TO NPH AND PREMIX IN POLAND?

✍ P McEwan; A Woehl; P Kawalec; J Lis; J Gierczynski; J Walczak 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 99 KB

PDB1 IMPROVED GLYCAEMIC CONTROL AND LESS

PDB1 IMPROVED GLYCAEMIC CONTROL AND LESS HYPOGLYCAEMIA WITH INSULIN GLARGINE COMPARED WITH NPH INSULIN IN PATIENTS WITH TYPE 2 DIABETES LEADS TO FEWER LONG-TERM COMPLICATIONS—RESULTS OF THE DIABETES MELLITUS SIMULATION MODEL

✍ S Maxion-Bergemann; E Müller; R Bergemann; S Walleser; E Huppertz 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 83 KB

Insulin detemir improves glycaemic contr

Insulin detemir improves glycaemic control with less hypoglycaemia and no weight gain in patients with type 2 diabetes who were insulin naive or treated with NPH or insulin glargine: clinical practice experience from a German subgroup of the PREDICTIVE study

✍ L. F. Meneghini; K. H. Rosenberg; C. Koenen; M. J. Merilainen; H.-J. Lüddeke 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 231 KB

Metabolic effects of pioglitazone in com

Metabolic effects of pioglitazone in combination with insulin in patients with type 2 diabetes mellitus whose disease is not adequately controlled with insulin therapy: Results of a six-month, randomized, double-blind, prospective, multicenter, parallel-group study

✍ Vinod Mattoo; David Eckland; Mario Widel; Santiago Duran; Carmen Fajardo; Jorma 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 1024 KB